Heterologous vector versus homologous mrna covid-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

HIGHLIGHTS

  • who: Daniel Mrak from the Laboratory testing Laboratory tests, including quantification of peripheral leukocytes, anti-SARS-Co, antibody testing, determination of SARS-CoV-2specific, and, cell responses, and anti-HLA antibodies are described in more detail in the Supplementary Information have published the paper: Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial, in the Journal: (JOURNAL) of 30/08/2022
  • what: The study was designed as described previously29 and is outlined in more detail in the Supplementary Information.
  • how: One limitation of this . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?